Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ly P Vu

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Blood Advances|November 2, 2022
miR-148a-3p and DDX6 functional link promotes survival of myeloid leukemia cellsMaryam Ghashghaei, Cong Truc Le, Haya Shaalan, et al.
Leukemia|November 17, 2024
The glycosyltransferase ST3GAL4 drives immune evasion in acute myeloid leukemia by synthesizing ligands for the glyco-immune checkpoint receptor Siglec-9Vignesh Krishnamoorthy, John Daly, Jimmy Kim, et al.
Cell Genomics|May 13, 2025
Nanopore direct RNA sequencing of human transcriptomes reveals the complexity of mRNA modifications and crosstalk between regulatory featuresYerin Kim, Luke Saville, Kieran O'Neill, et al.
Stem Cell Reports|March 11, 2015
The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cellsFabiana Perna, Ly P Vu, Maria Themeli, et al.
Cell Reports|August 15, 2019
m<sup>6</sup>A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric CommitmentYuanming Cheng, Hanzhi Luo, Franco Izzo, et al.
Cell Reports|December 17, 2013
PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complexLy P Vu, Fabiana Perna, Lan Wang, et al.
Nature Communications|April 26, 2020
HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cellsDiu T T Nguyen, Yuheng Lu, Eren L Chu, et al.
Cell Reports. Medicine|July 19, 2023
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myelomaFrancesco Di Meo, Anjushree Iyer, Keith Akama, et al.
Nature Medicine|September 19, 2017
The N<sup>6</sup>-methyladenosine (m<sup>6</sup>A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cellsLy P Vu, Brian F Pickering, Yuanming Cheng, et al.
Nature Cancer|August 30, 2021
Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemiaCamila Prieto, Diu T T Nguyen, Zhaoqi Liu, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Blood Advances|November 2, 2022
miR-148a-3p and DDX6 functional link promotes survival of myeloid leukemia cellsMaryam Ghashghaei, Cong Truc Le, Haya Shaalan, et al.
Leukemia|November 17, 2024
The glycosyltransferase ST3GAL4 drives immune evasion in acute myeloid leukemia by synthesizing ligands for the glyco-immune checkpoint receptor Siglec-9Vignesh Krishnamoorthy, John Daly, Jimmy Kim, et al.
Cell Genomics|May 13, 2025
Nanopore direct RNA sequencing of human transcriptomes reveals the complexity of mRNA modifications and crosstalk between regulatory featuresYerin Kim, Luke Saville, Kieran O'Neill, et al.
Stem Cell Reports|March 11, 2015
The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cellsFabiana Perna, Ly P Vu, Maria Themeli, et al.
Cell Reports|August 15, 2019
m<sup>6</sup>A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric CommitmentYuanming Cheng, Hanzhi Luo, Franco Izzo, et al.
Cell Reports|December 17, 2013
PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complexLy P Vu, Fabiana Perna, Lan Wang, et al.
Nature Communications|April 26, 2020
HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cellsDiu T T Nguyen, Yuheng Lu, Eren L Chu, et al.
Cell Reports. Medicine|July 19, 2023
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myelomaFrancesco Di Meo, Anjushree Iyer, Keith Akama, et al.
Nature Medicine|September 19, 2017
The N<sup>6</sup>-methyladenosine (m<sup>6</sup>A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cellsLy P Vu, Brian F Pickering, Yuanming Cheng, et al.
Nature Cancer|August 30, 2021
Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemiaCamila Prieto, Diu T T Nguyen, Zhaoqi Liu, et al.
Pageof 3